Palatin Technologies
PTN
#9923
Rank
NZ$67.78 M
Marketcap
NZ$39.81
Share price
4.59%
Change (1 day)
2,418.16%
Change (1 year)

Revenue for Palatin Technologies (PTN)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of NZ$0.62 Million a decrease over the revenue in the year 2023 that were of NZ$11.22 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Palatin Technologies from 1998 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A-100%
2024 NZ$0.62 M-94.47%
2023 NZ$11.22 M147.17%
2022 NZ$4.54 M316%
2021 NZ$1.09 M-274.04%
2020 -NZ$0.63 Million-100.7%
2019 NZ$89.65 M103.07%
2018 NZ$44.15 M-61.89%
2017 NZ$0.11 B
2016 N/A
2015 N/A-100%
2014 NZ$16.53 M
2013 N/A-100%
2012 NZ$0.05 M-83.17%
2011 NZ$0.32 M-94.37%
2010 NZ$5.82 M-79.2%
2009 NZ$27.99 M335.76%
2008 NZ$6.42 M-68.15%
2007 NZ$20.16 M-24.01%
2006 NZ$26.53 M-1.33%
2005 NZ$26.89 M102.09%
2004 NZ$13.3 M241%
2003 NZ$3.9 M93.6%
2002 NZ$2.01 M112.89%
2001 NZ$0.94 M-89.18%
2000 NZ$8.74 M59.88%
1999 NZ$5.47 M260.51%
1998 NZ$1.51 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
MediciNova
MNOV
NZ$0.23 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$4.64 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$1.43 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.43 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$0.33 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$159.50 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
NZ$0.68 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$100.61 BN/A๐Ÿ‡ฌ๐Ÿ‡ง UK